Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 421 AL 435

The Impact of the COVID-19 Pandemic on Family-Focused Care of People With Alzheimer's Disease and Related Dementias

Anderson JG, Jao YL.

J Fam Nurs. 2022 Aug;28(3):179-182. doi: 10.1177/10748407221108200.

Impaired time-distance reconfiguration patterns in Alzheimer's disease: a dynamic functional connectivity study with 809 individuals from 7 sites

Du K, Chen P, Zhao K, Qu Y, Kang X, Liu Y; Multi-center Alzheimer Disease Imaging Consortium.

BMC Bioinformatics. 2022 Jul 14;23(Suppl 6):280. doi: 10.1186/s12859-022-04776-x.

Spontaneous and induced adaptive immune responses in Alzheimer's disease: new insights into old observations

Chen Y, Colonna M.

Curr Opin Immunol. 2022 Aug;77:102233. doi: 10.1016/j.coi.2022.102233. Epub 2022 Jul 12.

Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways

Marmolejo-Garza A, Medeiros-Furquim T, Rao R, Eggen BJL, Boddeke E, Dolga AM.

Biochim Biophys Acta Mol Cell Res. 2022 Oct;1869(10):119326. doi: 10.1016/j.bbamcr.2022.119326. Epub 2022 Jul 14.

Particulate matter and Alzheimer's disease: an intimate connection

O'Piela DR, Durisek GR 3rd, Escobar YH, Mackos AR, Wold LE.

Trends Mol Med. 2022 Sep;28(9):770-780. doi: 10.1016/j.molmed.2022.06.004. Epub 2022 Jul 12.

Editorial: The dawn of a new era of Alzheimer's research and drug development

Hara Y, Fillit HM.

J Prev Alzheimers Dis. 2022;9(3):385-386. doi: 10.14283/jpad.2022.64.

Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report

Raman R, Aisen PS, Carillo MC, Detke M, Grill JD, Okonkwo OC, Rivera-Mindt M, Sabbagh M, Vellas B, Weiner M, Sperling R.

J Prev Alzheimers Dis. 2022;9(3):388-392. doi: 10.14283/jpad.2022.50.

Effects of Non-Invasive Brain Stimulation on Alzheimer's Disease

Gu L, Xu H, Qian F.

J Prev Alzheimers Dis. 2022;9(3):410-424. doi: 10.14283/jpad.2022.40.

Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding

Ruiz A, Sánchez D, Lafuente A, Ortega G, Buendía M, Papasey J, Jimeno SY, Badia FP, Palacio ME, Abdelnour C, Ramírez-Toraño F, Maestú F, Sáez ME, Tárraga L, Dagnelie PC, Boada M.

J Prev Alzheimers Dis. 2022;9(3):425-434. doi: 10.14283/jpad.2022.38.

Aging, Senescence, and Dementia

Behfar Q, Ramirez Zuniga A, Martino-Adami PV.

J Prev Alzheimers Dis. 2022;9(3):523-531. doi: 10.14283/jpad.2022.42.

Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules

Oumata N, Lu K, Teng Y, Cavé C, Peng Y, Galons H, Roques BP.

Eur J Med Chem. 2022 Oct 5;240:114578. doi: 10.1016/j.ejmech.2022.114578. Epub 2022 Jul 9.

Alterations of sleep oscillations in Alzheimer's disease: A potential role for GABAergic neurons in the cortex, hippocampus, and thalamus

Katsuki F, Gerashchenko D, Brown RE.

Brain Res Bull. 2022 Sep;187:181-198. doi: 10.1016/j.brainresbull.2022.07.002. Epub 2022 Jul 15.

Nanoparticles-based anti-aging treatment of Alzheimer's disease

Chu JJ, Ji WB, Zhuang JH, Gong BF, Chen XH, Cheng WB, Liang WD, Li GR, Gao J, Yin Y.

Drug Deliv. 2022 Dec;29(1):2100-2116. doi: 10.1080/10717544.2022.2094501.

A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer's disease and gastrointestinal tract disorders

Adewuyi EO, O'Brien EK, Nyholt DR, Porter T, Laws SM.

Commun Biol. 2022 Jul 18;5(1):691. doi: 10.1038/s42003-022-03607-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias